Akrich, M. 1992. The Description of Technical Objects, in Bijker, W. and Law, J. (eds.) Shaping Technology/Building Society: Studies in Sociotechnical Change. Cambridge, MA: MIT Press, pp. 205–224.Google Scholar

American College of Medical Genetics (ACMG). 2005. Newborn Screening: Toward a Uniform Screening Panel and System. Available at http://mchb.hrsa.gov/screening.Google Scholar

Angastiniotis, M. A., Kyriakidou, S., and Hadjiminas, M. 1986. How Thalassaemia Was Controlled in Cyprus. World Health Forum 7: 291–297.Google Scholar

Bowker, G. and Star, S. L. 1999. Sorting Things Out. Cambridge: MIT Press.Google Scholar

Bornik, Z. B. and Dowlatabadia, H. 2008. Genomics in Cyprus: Challenging the Social Norms. Technology in Society 30(1): 84–93.Google Scholar

Borry, P., Clarke, A., and Dierickx, K. 2008. Carrier Screening: Look before You Leap. Carrier Screening for Type 1 Gaucher Disease: Difficult Questions. European Journal of Human Genetics 16(2): 139–140.Google Scholar

Broide, E., Zeigler, M., Eckstein, J., and Bach, G. 1993. Screening for Carriers of Tay-Sachs Disease in the Ultraorthodox Ashkenazi Jewish Community in Israel. American Journal of Medical Genetics 47: 21–35.Google Scholar

Bryant, L., Ahmed, S., and Hewison, J. 2008. Conveying Information about Screening, in Rodeck, C. and Whittle, M. (eds.) Fetal Medicine: Basic Science and Clinical Practice Edinburgh: Elsevier, pp. 225–234.Google Scholar

Clayton, E. and Brothers, K. B. 2015. State-Offered Ethnically Targeted Reproductive Genetic Testing. Genetics in Medicine DOI: 10.1038/gim.2015.74.Google Scholar

Cohen, B. E., Szeinberg, A., Peled, I., Szeinberg, B., Bar-Or, R. 1966. Screening Program for Early Detection of Phenylketonuria in the Newborn in Israel. Israel Journal of Medical Science 2(2): 156–164.Google Scholar

Ekstein, J. and Katzenstein, H. 2001. The Dor Yeshorim Story: Community-Based Carrier Screening for Tay-Sachs Disease. Advances in Genetics 44: 297–310.Google Scholar

Epstein, L., Gofin, J., Gofin, R., and Neumark, Y. 2002. The Jerusalem Experience: Three Decades of Services, Research, and Training in Community-Oriented Primary Care. American Journal of Public Health 92(11): 1717–21.Google Scholar

Fullwiley, D. 2007. The Molecularization of Race: Institutionalizing Racial Difference in Pharmacogenetics Practice. Science as Culture 16(1): 1–30.Google Scholar

Geisler, E. and Heller, O. 1998. Management of Medical Technology: Theory, Practice and Cases. Berlin: Springer.Google Scholar

Gollust, S. E., Apse, K., Fuller, B. P., Miller, P. S., and Biesecker, B. B. 2005. Community Involvement in Developing Policies for Genetic Testing: Assessing the Interests and Experiences of Individuals Affected by Genetic Conditions. American Journal of Public Health 95(1): 35–41.Google Scholar

Hashiloni-Dolev, Y. 2007. A Life (Un)Worthy of Living: Reproductive Genetics in Israel and Germany. Berlin: Springer-Kluwer.Google Scholar

Hofmann, B. 2002. Is There a Technological Imperative in Health Care? International Journal of Technology Assessment in Health Care 18(3): 675–689.Google Scholar

Israeli Ministry of Health 2005. General Manager’s Publication Regarding Instructions of the Supreme Committee on Experiments on Human Beings Regarding the Establishment and Utilization of Genetic Samples Banks, No. 01/05, January 2, 2005 (in Hebrew).Google Scholar

Israeli Ministry of Health. Expecting Birth (Including Screening for Healthy Newborns). Public Health Services (leaflet). May 2009. Jerusalem: The Government’s Publication Agency (in Hebrew).Google Scholar

Juengst, E. T. 1998. Groups as Gatekeepers to Genomic Research: Conceptually Confusing, Morally Hazardous, and Practically Useless. Kennedy Institute of Ethics Journal 8(2): 183–200.Google Scholar

Kaback, M. M. 2001. Screening and Prevention in Tay-Sachs Disease: Origins, Update, and Impact. Advanced Genetics 44: 253–265.Google Scholar

Kark, S. L. 1981. The Practice of Community-Oriented Primary Care. New York: Appleton-Century-Crofts.Google Scholar

Khoury, M. I., Burke, W., and Thomson, E. I. 2000. Genetics and Public Health in the 21st Century. Oxford: Oxford University Press.Google Scholar

Kirsh, N. 2003. Population Genetics in Israel in the 1950s: The Unconscious Internalization of Ideology. Isis, 94: 631–655.Google Scholar

Lakeman, P., Plass, A. M. C., Henneman, L., Bezemer, P. D., Cornel, M. C., and ten Kate, L. P. 2008. Three-Month Follow-Up of Western and Non-Western Participants in a Study on Preconceptional Ancestry-Based Carrier Couple Screening for Cystic Fibrosis and Hemoglobinopathies in the Netherlands. Genetics in Medicine 10: 820–830.Google Scholar

Lakeman, P., Plass, A. M. C., Henneman, L., Bezemer, P. D., Cornel, M. C., and ten Kate, L. P. 2009. Preconceptional Ancestry-Based Carrier Couple Screening for Cystic Fibrosis and Haemoglobinopathies: What Determines the Intention to Participate or Not and Actual Participation? European Journal of Human Genetics 17(8): 999–1009.Google Scholar

Marks, J. 2002. What It Means to Be 98% Chimpanzee. Berkeley: University of California Press.Google Scholar

Massie, J., Forbes, R., duSart, D., Bankier, A., and Delatycki, M. B. 2007. Community-wide Screening for Cystic Fibrosis Carriers Could Replace Newborn Screening for the Diagnosis of Cystic Fibrosis. Journal of Paediatrics and Child Health 43(11): 721–723.Google Scholar

McCoyd, J. 2010. Authoritative Knowledge, the Technological Imperative and Women’s Responses to Prenatal Diagnostic Technologies. Culture, Medicine & Psychiatry 34(4): 590–614.Google Scholar

Ong, A. 2015. Why Singapore Trumps Iceland. Journal of Cultural Economy, online first DOI: 10.1080/17530350.2015.1009149.Google Scholar

Paul, D. 2008. Patient Advocacy in Newborn Screening: Continuities and Discontinuities. American Journal of Medical Genetics, Part C 148C: 8–14.Google Scholar

Prainsack, B. 2006a. “Natural Forces”: The Regulation and Discourse of Genomics and Advanced Medical Technologies in Israel, in Glasner, P., Atkinson, P., and Greenslade, H. (eds.) New Genetics, New Social Formations. New York: Routledge, pp. 231–253.Google Scholar

Prainsack, B. 2006b. Negotiating Life: The Regulation of Embryonic Stem Cell Research and Human Cloning in Israel. Social Studies of Science 36(2): 173–205.Google Scholar

Prainsack, B. 2007. Research Populations: Biobanks in Israel. New Genetics and Society 26(1): 85–103.Google Scholar

Prainsack, B. and Firestine, O. 2006. Science for Survival: Biotechnology Regulation in Israel. Science and Public Policy 33(1): 33–46.Google Scholar

Prainsack, B. and Hashiloni-Dolev, Y. 2008. Faith and Nationhood, in Atkinson, P. Glasner, P., and Lock, M. (eds.) Handbook of Genetics and Society: Mapping the New Genomic Era. London: Routledge, chapter 28.Google Scholar

Prainsack, B. and Siegal, G. 2006. The Rise of Genetic Couplehood: A Comparative View of Pre-marital Genetic Screening. Biosocieties 1: 17–36.Google Scholar

Price, C. L., Johnson, M. T., Lindsay, T., Dalton, D., and DeBaun, M. R. 2008, November 25. The Sickle Cell Sabbath: A Community Program Increases First-Time Blood Donors in the African-American Faith Community. Transfusion. http://dx.doi.org/10.1111/j.1537–2995.2008.02009.x.Google Scholar

Raffle, A. E. 2001. Information about Screening: Is It to Achieve High Uptake or to Ensure Informed Choice? Health Expectations 4(2): 92–98.Google Scholar

Raz, A. 2004. Important to Test, Important to Support: Attitudes toward Disability Rights and Prenatal Diagnosis among Leaders of Support Groups for Genetic Disorders in Israel. Social Science and Medicine 59: 1857–1866.Google Scholar

Raz, A. 2009. Community Genetics and Genetic Alliances: Eugenics, Carrier Testing, and Networks of Risk. New York and London: Routledge.Google Scholar

Raz, A. and Schicktanz, S. 2009a. Lay Perceptions of Genetic Testing in Germany and Israel: The Interplay of National Culture and Individual Experience. New Genetics and Society 28(4): 401–414.Google Scholar

Raz, A. and Schicktanz, S. 2009b. Diversity and Uniformity in Genetic Responsibility: Moral Attitudes of Patients, Relatives and Lay People in Germany and Israel. Medicine, Healthcare and Philosophy 12(4): 433–442.Google Scholar

Reardon, J. 2004. Race to the Finish: Identity and Governance in an Age of Genomics. Princeton, NJ: Princeton University Press.Google Scholar

Remennick, L. 2006. The Quest after the Perfect Baby: Why Do Israeli Women Seek Prenatal Genetic Testing? Sociology of Health and Illness 28(1): 21–53.Google Scholar

Sagi, M. and Uhlmann, W. R. 2013. Genetic Counseling Services and Training of Genetic Counselors in Israel: An Overview. Journal of Genetic Counseling 22: 890–896.Google Scholar

Shaw, A. 2008. Negotiating Risk: British Pakistani Experiences of Genetics. Oxford: Berghan.Google Scholar

Stewart, A., Brice, P., Burton, H., Pharao, P., Sanderson, S., and Zimmern, R. 2007. Genetics, Health Care and Public Policy: An Introduction to Public Health Genetics. Cambridge: Cambridge University Press.Google Scholar

ten Kate, L. P. 2005. Community Genetics: A Bridge between Clinical Genetics and Public Health Community Genetics 8(1): 7–11.Google Scholar

Timmermans, S. and Buchbinder, M. 2013. Saving Babies? The Consequences of Newborn Genetic Screening. Chicago, IL: University of Chicago Press.Google Scholar

Timmermans, S. and Shostak, S. 2016. Gene Worlds. Health 20(1): 33–48.Google Scholar

Wailoo, K. 2001. Dying in the City of the Blues: Sickle Cell Anemia and the Politics of Race and Health. Chapel Hill: University of North Carolina Press.Google Scholar

Zlotogora, J. 2009. Population Programs for the Detection of Couples at Risk for Severe Monogenic Genetic Diseases. Human Genetics 126(2): 247–253.Google Scholar

Zlotogora, J. 2014. Genetics and Genomic Medicine in Israel. Molecular Genetics & Genomic Medicine 2(2): 85–94.Google Scholar

Zlotogora, J. 2015. Using Community Genetics for Healthy Consanguinity, in Shaw, A. and Raz, A. (eds.) Cousin Marriages: Between Tradition, Genetic Risk and Cultural Change. London: Berghahn, pp. 175–185.Google Scholar

Zlotogora, J. R., Carmi, B. L., and Shalev, A. 2009. A Targeted Population Carrier Screening Program for Severe and Frequent Genetic Diseases in Israel. European Journal of Human Genetics 17(5): 591–597.Google Scholar

Zlotogora, J. and Israeli, A. 2009. A Comprehensive Screening Program for Cystic Fibrosis. The Israel Medical Association Journal 11(9): 555–557.Google Scholar

Zlotogora, J., and Leventhal, A. 2000. Screening for Genetic Disorders among Jews: How Should the Tay-Sachs Screening Be Continued? Israel Medical Association Journal 2(9), September: 665–667.Google Scholar

Zlotogora, J. et al. 2015. The Israeli National Population Program of Genetic Carrier Screening for Reproductive Purposes. Genetics in Medicine advance online publication. DOI:10.1038/gim.2015.55.Google Scholar